News|Articles|November 20, 2023
Data is Becoming a Differentiator for Hubs that Support Specialty Drugs
Author(s)CareMetx
In a recent study, CareMetx engaged with senior leadership at leading biopharmaceutical manufacturers, aiming to evaluate the optimal ways in which Hub data can enhance manufacturer support. These findings can serve as a valuable guide for manufacturers seeking insights on optimizing their utilization of Hub data.
Advertisement
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
BoomRx Expands Access to Oral Semaglutide and Tirzepatide Using Nanoemulsion Delivery
2
The Hidden Economics of Health Insurance Affordability
3
Pharma Pulse: Novartis Warns of Trade Fragmentation; Hospital M&A Hits Record Low; Copay Shock Warning
4
Evaluate’s 2026 Pharma Forecast Signals Cautious Recovery, Rising M&A, and GLP-1 Market Shifts
5